The rationale for using apoA-I as a clinical marker of cardiovascular risk

Journal of Internal Medicine
Philip J Barter, K-A Rye

Abstract

An inverse relationship between the concentration of high-density lipoprotein (HDL) cholesterol and the risk of developing cardiovascular is well established. There are several documented functions of HDLs that may contribute to a protective role of these lipoproteins. These include the ability of HDLs to promote the efflux of cholesterol from macrophages and foam cells in the artery wall and to anti-inflammatory/antioxidant properties of these lipoproteins. The fact that the main apolipoprotein of HDLs, apoA-I, plays a prominent role in each of these functions adds support to the view that apoA-I should be measured as a component of the assessment of cardiovascular risk in humans.

References

Oct 1, 1979·The Journal of Clinical Investigation·A R TallJ W Riley
Jan 30, 1978·Biochemical and Biophysical Research Communications·E J SchaeferH B Brewer
Nov 1, 1992·Seminars in Liver Disease·J L Dixon, H N Ginsberg
Sep 24, 1981·Biochimica Et Biophysica Acta·P J BlancheA V Nichols
Nov 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·G W CockerillP J Barter
Jun 27, 1995·Biochimica Et Biophysica Acta·H Q LiangP J Barter
Jul 1, 1995·The Journal of Clinical Investigation·G A FrancisJ F Oram
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·A S PlumpJ L Breslow
Mar 1, 1993·The Journal of Cell Biology·E M DanielsenM D Poulsen
Sep 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·D T AshbyP J Barter
Sep 17, 1999·Atherosclerosis·K A RyeP J Barter
Sep 5, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·G W CockerillC Thiemermann
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·John F Oram
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Patricia G YanceyGeorge H Rothblat
May 10, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Nan Wang, Alan R Tall
Nov 1, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Kerry-Anne Rye, Philip J Barter
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Steven E NissenRichard Kerensky
Jan 7, 2004·Cerebrovascular Diseases·Roberto PaternòMarkus G Lang
Jun 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nan WangAlan R Tall
Oct 16, 2004·Circulation Research·Philip J BarterAlan M Fogelman
Jan 15, 2005·Current Opinion in Lipidology·Ji-Young Lee, John S Parks
Sep 6, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Stephen J NichollsPhilip J Barter

❮ Previous
Next ❯

Citations

Mar 21, 2009·Human Genetics·Himadri RoySeppo Yla-Herttuala
Jan 5, 2008·Current Atherosclerosis Reports·Allan D Sniderman, Robert S Kiss
Jul 24, 2012·Metabolic Syndrome and Related Disorders·Takashi AbeTetsuo Fukunaga
Apr 17, 2008·International Journal of Clinical Practice·A S Wierzbicki
Jun 16, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Takao MaruyamaToshiaki Hasuike
May 3, 2014·International Journal of Nephrology·Mohsen NafarRoman A Zubarev
Jul 16, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Min Kyung KimKyung Rae Kim
Jan 19, 2010·Clinical Biochemistry·Josefin AhnströmBjörn Dahlbäck
Oct 2, 2008·Journal of Biomedicine & Biotechnology·Sophie Collot-TeixeiraJohn L McGregor
Jul 22, 2008·Metabolism: Clinical and Experimental·Lihe ZhangH Henry Dong
May 23, 2007·Journal of Cardiac Failure·Grigorios Giamouzis, Javed Butler
Nov 17, 2009·Journal of Cellular and Molecular Medicine·Elsa GenovéCarlos E Semino
Apr 23, 2013·Contrast Media & Molecular Imaging·Jens O LagerstedtJohn C Voss
Dec 24, 2010·British Journal of Clinical Pharmacology·Sharon M L WallaceRajesh K Kharbanda
Jan 14, 2009·Nature Reviews. Genetics·Robert A Hegele
Mar 28, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Marja-Riitta TaskinenUNKNOWN FIELD study investigators
Jun 9, 2007·Current Opinion in Cardiology·Göran Walldius, Ingmar Jungner
Mar 7, 2008·European Journal of Human Genetics : EJHG·Patrik K E MagnussonNancy L Pedersen
Feb 22, 2008·Journal of Cardiovascular Pharmacology·Jonas Heilskov GraversenSøren Kragh Moestrup
Oct 18, 2007·Current Opinion in Endocrinology, Diabetes, and Obesity·Allan D Sniderman
Dec 7, 2007·The Journal of Clinical Endocrinology and Metabolism·Olivier ValkenburgJoop S E Laven
Feb 23, 2020·Photodiagnosis and Photodynamic Therapy·Maria Camila Pruper de FreitasNágila Raquel Teixeira Damasceno
Nov 5, 2019·Thrombosis Research·Ida GregersenPer Morten Sandset

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.